(S)-Methyl 2-(((benzyloxy)carbonyl)amino)-3-(tert-butoxy)propanoate

Catalog No. :
ACKFAV408
CAS No. :
1872-59-9
Molecular Formula :
C16H23NO5
Molecular Weight :
309.36

IUPAC Name:methyl N-((benzyloxy)carbonyl)-O-(tert-butyl)-L-serinate

(S)-Methyl 2-(((benzyloxy)carbonyl)amino)-3-(tert-butoxy)propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g95%$157.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-Methyl 2-(((benzyloxy)carbonyl)amino)-3-(tert-butoxy)propanoate
IUPAC Namemethyl N-((benzyloxy)carbonyl)-O-(tert-butyl)-L-serinate
MDL No.MFCD00191072
Molecular FormulaC16H23NO5
Molecular Weight309.36
SMILES[H][C@@](COC(C)(C)C)(NC(=O)OCC1=CC=CC=C1)C(=O)OC
InChI KeyUMAXPCYVVRYQNO-ZDUSSCGKSA-N
SynonymDTXSID80562393 | AM82235 | A880593 | CS-W012070 | BAA87259 | O-tert-Butyl-N-carbobenzoxy-L-serine Methyl Ester | AKOS015911690 | O-tert-Butyl-N-carbobenZoxy-L-serine methyl ester (CbZ-L-Ser(tBu)-OMe) | HY-W011354 | AS-46847 | MFCD00191072 | Z-O-tert.butyl
CAS No.1872-59-9
PubChem CID14629315

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKFAV408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACENAV201 route compound structure diagram
    ACENAV2011676-81-9 In Stock
  4. Then
  5. ACKFAV408 route product structure diagram
    ACKFAV4081872-59-9
Inquiry

2. ACKFAV408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLZRW329 route compound structure diagram
    ACLZRW32917114-97-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKFAV408 route product structure diagram
    ACKFAV4081872-59-9
Inquiry

Comments (0)